Pear Therapeutic a News

Pear Therapeutic a Aktie VALOR 115286588 / ISIN US7047231052

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Trading-Depot

Aktion

Portfolio

Watchlist

07.04.23	Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process (Businesswire)
17.03.23	Pear Therapeutics Announces Process Exploring Strategic Alternatives (Businesswire)
27.02.23	Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference (Businesswire)
02.02.23	Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Businesswire)
26.01.23	Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders (Businesswire)
18.01.23	Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List (Businesswire)
12.01.23	California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program (Businesswire)
10.01.23	Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics (Businesswire)
04.01.23	Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States (Businesswire)
15.12.22	Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP (Businesswire)
21.11.22	Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference (Businesswire)
14.11.22	Pear Therapeutics Reports Third Quarter 2022 Results (Businesswire)
10.11.22	Pear Therapeutics to Participate in the BTIG Digital Health Forum (Businesswire)
07.11.22	Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe (Businesswire)
03.11.22	State of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction Crisis (Businesswire)
01.11.22	Pear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference (Businesswire)
31.10.22	Pear Therapeutics to Issue Third Quarter 2022 Financial Results on Monday, November 14, 2022 (Businesswire)

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	99.30	0.42 %	K V
UBS Group	30.78	0.33 %	K V
Part Grp Hldg	990.40	0.26 %	K V
Kuehne+Nagel Int	154.70	0.19 %	K V
Alcon	59.84	0.17 %	K V
Nestle	76.51	-1.21 %	K V
Zurich Insur Gr	561.40	-1.30 %	K V
CieFinRichemont	158.30	-1.43 %	K V
Swiss Re	146.95	-1.67 %	K V